Finally, the four-gene signature (SPP1, MYBL2, TRNP1, and FTCD) was identified from more than 1000 combinations and splitting the HCC patients with different OS into the low-risk and high-risk groups in the TCGA and ICGC cohorts. The gene discussed is FTCD; the disease is hepatocellular carcinoma.